Society of Nuclear Medicine

SHERPA: Unknown

People

  1. Humm
    Humm
  2. Zanzonico
    Zanzonico
  3. Schoder
    Schoder
  4. Lewis
    Lewis
  5. O'Donoghue
    O'Donoghue
  6. Blasberg
    Blasberg
  7. Morris
    Morris
  8. Kesner
    Kesner
  9. Carter
    Carter
  10. Scheinberg
    Scheinberg

Groups

  1. Radiology, Department of (703)
  2. Molecular Imaging and Therapy Service (577)
  3. GSK Faculty (478)
  4. Sloan Kettering Institute Faculty (388)
  5. Molecular Pharmacology and Chemistry Program Faculty (383)
  6. Medical Physics (308)
  7. Sloan Kettering Institute Postdocs (271)
  8. Department of Medicine (217)
  9. Radiochemistry and Imaging Sciences Service (213)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (183)
Search Within
Formats
  1. Journal Article (469)
  2. Meeting Abstract (422)
  3. Review (32)
  4. Editorial (25)
  5. Miscellaneous (7)
  6. Correspondence (6)
  7. Guidelines (3)
  8. Conference Paper (2)
  9. Research Letter (1)
Groups
  1. Radiology, Department of (703)
  2. Molecular Imaging and Therapy Service (577)
  3. GSK Faculty (478)
  4. Sloan Kettering Institute Faculty (388)
  5. Molecular Pharmacology and Chemistry Program Faculty (383)
  6. Medical Physics (308)

More Groups

People
  1. Steven Larson (294)
  2. John Humm (116)
  3. Pat Zanzonico (99)
  4. Ronald Finn (99)
  5. Heiko Schoder (97)
  6. Jason Lewis (90)

More People

Years
  1. 2025 (33)
  2. 2024 (51)
  3. 2023 (54)
  4. 2022 (24)
  5. 2021 (38)
  6. 2020 (47)

More Years

Publications
  1. Journal of Nuclear Medicine (967)

Results (967)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative evaluation of the new MIRDcalc dosimetry software across a compendium of radiopharmaceuticals
    Meeting Abstract

    Carter, L.; Ocampo Ramos, J.; Zanzonico, P.; Bolch, W.; Kesner, A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Low incidence rates of mucositis, febrile neutropenia or sepsis in the prospective, randomized phase 3 SIERRA trial for patients with relapsed or refractory acute myeloid leukemia with targeted delivery of anti-CD45 iodine ((131)I) apamistamab [Iomab-B]
    Meeting Abstract

    Natwa, M.; Passalaqua, S.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Relationship of marrow radiation dose and timing of engraftment for targeted radioimmunotherapy with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] in patients with active relapsed or refractory acute myeloid leukemia
    Meeting Abstract

    Passalaqua, S.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Patient size-dependent dosimetry methodology applied to (18)F-FDG using new ICRP mesh phantoms
    Journal Article

    Carter, L. M.; Choi, C.; Krebs, S.; Beattie, B. J.; Kim, C. H.; Schoder, H.; Bolch, W. E.; Kesner, A. L.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Radioembolization versus bland or chemoembolization for liver-dominant neuroendocrine tumors: Is it an either/or question?
    Editorial

    Strosberg, J.; El-Haddad, G.; Al-Toubah, T.; Reidy-Lagunes, D.; Ziv, E.; Mahvash, A.; Dasari, A.; Philip, P.; Soulen, M. C.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • 2021 SNMMI Highlights Lecture: Oncology and Therapy, Part 1
    Editorial

    Schöder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • 2021 SNMMI Highlights Lecture: Oncology and Therapy, Part 2
    Editorial

    Schöder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Quantification of metastatic prostate cancer whole-body tumor burden with (18)F-FDG PET parameters and associations with overall survival after first-line abiraterone or enzalutamide: A single-center retrospective cohort study
    Journal Article

    Wibmer, A. G.; Morris, M. J.; Gonen, M.; Zheng, J.; Hricak, H.; Larson, S.; Scher, H. I.; Vargas, H. A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • PARP1: A potential molecular marker to identify cancer during colposcopy procedures
    Journal Article

    de Souza França, P. D.; Guru, N.; Kostolansky, A. R.; Mauguen, A.; Pirovano, G.; Kossatz, S.; Roberts, S.; Abrahão, M.; Patel, S. G.; Park, K. J.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save

    • Society of Nuclear Medicine – authorized name for: